|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Head of Medical - Sanofi Pasteur Korea
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
5³â¡è |
ä¿ë½Ã |
06.16 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
06.16 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Market Access Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
ä¿ë½Ã |
06.16 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Clinical Project Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
06.16 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Regulatory Affairs Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
07.09 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Public Affairs manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
15³â¡è |
ä¿ë½Ã |
07.09 |
|
|
´õ¿þÀÌÄ¿¹Â´ÏÄÉÀÌ¼Ç |
ÀÓ»ó½ÃÇè CRA °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.01 |
|
|
Áö¸à½ºÇï½Ã´Ï¾î½º(ÁÖ) |
CT Product Specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.23 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
Omnichannel Engagement Lead
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
5³â¡è |
ä¿ë½Ã |
04.06 |
|
|
»ïÀÏÁ¦¾à(ÁÖ) |
¸¶ÄÉÆú»ºÎ ETC¸¶ÄÉÆà ´ã´ç ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
2³â¡è |
ä¿ë½Ã |
12.22 |
|
|
À£Æ®ÁÖ½Äȸ»ç |
ÀÓ»ó½ÃÇè ¸Å´ÏÀú (Clinical Research Manager)
¼¿ï ¼Ãʱ¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
»ó½Ãä¿ë |
08.13 |
|
|
JWÁß¿ÜÁ¦¾à |
[JW½Å¾à] Å¥·¹À̼ÇPM ´ëÁ¹ °è¾àÁ÷ ä¿ë
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.02 |
|
|
(ÁÖ)Å¥¶óƼ½º |
Å¥¶óƼ½º »ç¾÷°³¹ßÆÀ Á¤±ÔÁ÷ ä¿ë °ø°í
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
2³â¡è |
ä¿ë½Ã |
05.16 |
|
|
(ÁÖ)Å¥¶óƼ½º |
ÀÓ»óÀÎÇã°¡ÆÀ PV Á¤±ÔÁ÷ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
5³â¡è |
ä¿ë½Ã |
06.22 |
|
|
(ÁÖ)Å¥¶óƼ½º |
ÀÓ»ó°³¹ßÆÀ ÀÓ»óQA Á¤±ÔÁ÷ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.13 |
|